Annual FCF
-$452.91 M
+$58.29 M+11.40%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual free cash flow is -$452.91 million, with the most recent change of +$58.29 million (+11.40%) on December 31, 2023.
- During the last 3 years, BPMC annual FCF has fallen by -$836.78 million (-217.98%).
- BPMC annual FCF is now -217.98% below its all-time high of $383.88 million, reached on December 31, 2020.
Performance
BPMC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$13.66 M
+$36.98 M+73.02%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly free cash flow is -$13.66 million, with the most recent change of +$36.98 million (+73.02%) on September 30, 2024.
- Over the past year, BPMC quarterly FCF has increased by +$97.07 million (+87.66%).
- BPMC quarterly FCF is now -102.20% below its all-time high of $622.32 million, reached on September 30, 2020.
Performance
BPMC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$250.52 M
+$97.07 M+27.93%
September 30, 2024
Summary
- As of February 7, 2025, BPMC TTM free cash flow is -$250.52 million, with the most recent change of +$97.07 million (+27.93%) on September 30, 2024.
- Over the past year, BPMC TTM FCF has increased by +$241.67 million (+49.10%).
- BPMC TTM FCF is now -161.54% below its all-time high of $407.06 million, reached on June 30, 2021.
Performance
BPMC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BPMC Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.4% | +87.7% | +49.1% |
| 3 y3 years | -218.0% | +89.7% | +51.4% |
| 5 y5 years | -141.3% | +89.7% | +51.4% |
BPMC Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.1% | at high | +95.0% | at high | +62.1% |
| 5 y | 5-year | -218.0% | +19.1% | -102.2% | +95.0% | -161.5% | +62.1% |
| alltime | all time | -218.0% | +19.1% | -102.2% | +95.0% | -161.5% | +62.1% |
Blueprint Medicines Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.66 M(-73.0%) | -$250.52 M(-27.9%) |
| Jun 2024 | - | -$50.64 M(-50.7%) | -$347.59 M(-19.2%) |
| Mar 2024 | - | -$102.62 M(+22.7%) | -$429.98 M(-5.1%) |
| Dec 2023 | -$452.91 M(-11.4%) | -$83.60 M(-24.5%) | -$452.91 M(-8.0%) |
| Sep 2023 | - | -$110.73 M(-16.8%) | -$492.19 M(-4.4%) |
| Jun 2023 | - | -$133.03 M(+6.0%) | -$515.08 M(+2.4%) |
| Mar 2023 | - | -$125.55 M(+2.2%) | -$502.86 M(-1.6%) |
| Dec 2022 | -$511.20 M(-8.7%) | -$122.89 M(-8.0%) | -$511.20 M(-22.8%) |
| Sep 2022 | - | -$133.62 M(+10.6%) | -$661.83 M(+5.9%) |
| Jun 2022 | - | -$120.81 M(-9.8%) | -$624.81 M(+10.0%) |
| Mar 2022 | - | -$133.88 M(-51.1%) | -$567.82 M(+1.4%) |
| Dec 2021 | -$559.89 M(-245.9%) | -$273.52 M(+183.2%) | -$559.89 M(+79.5%) |
| Sep 2021 | - | -$96.59 M(+51.3%) | -$311.86 M(-176.6%) |
| Jun 2021 | - | -$63.83 M(-49.3%) | $407.06 M(+10.4%) |
| Mar 2021 | - | -$125.95 M(+394.2%) | $368.78 M(-3.9%) |
| Dec 2020 | $383.88 M(-231.5%) | -$25.49 M(-104.1%) | $383.88 M(+6.5%) |
| Sep 2020 | - | $622.32 M(-709.5%) | $360.58 M(-206.2%) |
| Jun 2020 | - | -$102.11 M(-7.9%) | -$339.63 M(+5.8%) |
| Mar 2020 | - | -$110.85 M(+127.2%) | -$320.92 M(+9.9%) |
| Dec 2019 | -$292.03 M | -$48.79 M(-37.4%) | -$292.03 M(-6.2%) |
| Sep 2019 | - | -$77.89 M(-6.6%) | -$311.25 M(+7.0%) |
| Jun 2019 | - | -$83.40 M(+1.8%) | -$290.99 M(+36.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$81.96 M(+20.5%) | -$213.77 M(+13.9%) |
| Dec 2018 | -$187.69 M(+38.6%) | -$68.01 M(+18.0%) | -$187.69 M(+13.7%) |
| Sep 2018 | - | -$57.62 M(+832.3%) | -$165.01 M(+19.2%) |
| Jun 2018 | - | -$6.18 M(-88.9%) | -$138.38 M(-13.5%) |
| Mar 2018 | - | -$55.88 M(+23.3%) | -$159.96 M(+18.2%) |
| Dec 2017 | -$135.38 M(+403.9%) | -$45.33 M(+46.3%) | -$135.38 M(+24.4%) |
| Sep 2017 | - | -$30.99 M(+11.6%) | -$108.86 M(+12.2%) |
| Jun 2017 | - | -$27.76 M(-11.3%) | -$97.03 M(+10.7%) |
| Mar 2017 | - | -$31.29 M(+66.3%) | -$87.65 M(+226.2%) |
| Dec 2016 | -$26.87 M(-26.5%) | -$18.82 M(-1.8%) | -$26.87 M(+8.1%) |
| Sep 2016 | - | -$19.16 M(+4.2%) | -$24.85 M(+30.9%) |
| Jun 2016 | - | -$18.39 M(-162.3%) | -$18.98 M(+59.0%) |
| Mar 2016 | - | $29.49 M(-275.5%) | -$11.94 M(-67.3%) |
| Dec 2015 | -$36.56 M(+1.3%) | -$16.80 M(+26.4%) | -$36.56 M(+15.2%) |
| Sep 2015 | - | -$13.29 M(+17.1%) | -$31.74 M(+16.7%) |
| Jun 2015 | - | -$11.34 M(-332.9%) | -$27.21 M(+10.9%) |
| Mar 2015 | - | $4.87 M(-140.7%) | -$24.52 M(-32.1%) |
| Dec 2014 | -$36.10 M(+87.2%) | -$11.98 M(+36.8%) | -$36.10 M(+49.7%) |
| Sep 2014 | - | -$8.76 M(+1.1%) | -$24.12 M(+57.0%) |
| Jun 2014 | - | -$8.66 M(+29.2%) | -$15.37 M(+129.2%) |
| Mar 2014 | - | -$6.70 M | -$6.70 M |
| Dec 2013 | -$19.28 M | - | - |
FAQ
- What is Blueprint Medicines annual free cash flow?
- What is the all time high annual FCF for Blueprint Medicines?
- What is Blueprint Medicines annual FCF year-on-year change?
- What is Blueprint Medicines quarterly free cash flow?
- What is the all time high quarterly FCF for Blueprint Medicines?
- What is Blueprint Medicines quarterly FCF year-on-year change?
- What is Blueprint Medicines TTM free cash flow?
- What is the all time high TTM FCF for Blueprint Medicines?
- What is Blueprint Medicines TTM FCF year-on-year change?
What is Blueprint Medicines annual free cash flow?
The current annual FCF of BPMC is -$452.91 M
What is the all time high annual FCF for Blueprint Medicines?
Blueprint Medicines all-time high annual free cash flow is $383.88 M
What is Blueprint Medicines annual FCF year-on-year change?
Over the past year, BPMC annual free cash flow has changed by +$58.29 M (+11.40%)
What is Blueprint Medicines quarterly free cash flow?
The current quarterly FCF of BPMC is -$13.66 M
What is the all time high quarterly FCF for Blueprint Medicines?
Blueprint Medicines all-time high quarterly free cash flow is $622.32 M
What is Blueprint Medicines quarterly FCF year-on-year change?
Over the past year, BPMC quarterly free cash flow has changed by +$97.07 M (+87.66%)
What is Blueprint Medicines TTM free cash flow?
The current TTM FCF of BPMC is -$250.52 M
What is the all time high TTM FCF for Blueprint Medicines?
Blueprint Medicines all-time high TTM free cash flow is $407.06 M
What is Blueprint Medicines TTM FCF year-on-year change?
Over the past year, BPMC TTM free cash flow has changed by +$241.67 M (+49.10%)